A New Device for Early Detection of Breast Disease: Stakeholders Perspective Analysis in Brazil/LATAM/LMIC
Author(s)
ELIO TANAKA, Sr., MD1, Jorge Salazar, MEDICAL DEVIDE RESEARCH SPONSOR2, Claudio Tafla, RESEARCHER3, EDUARDO Ramos, RESEARCHER4, FABIO FRANCO, RESEARCHER4, Francisco Prota, MD5, Ana Paula Rodrigues, .6, Débora Fernanda Guisso, MD6.
1MEDICAL AUDIT, TNK MEDICAL AUDIT INSTITUTION, CURITIBA, Brazil, 2RESEARCH, WELWAZE, MIAMI, FL, USA, 3MEDICAL AUDIT, TNK, CAMPINAS, Brazil, 4MEDICAL AUDIT, TNK, CURITIBA PR, Brazil, 5TNK, CURITIBA , PR, Brazil, 6Research Student, TNK, São Paulo, Brazil.
1MEDICAL AUDIT, TNK MEDICAL AUDIT INSTITUTION, CURITIBA, Brazil, 2RESEARCH, WELWAZE, MIAMI, FL, USA, 3MEDICAL AUDIT, TNK, CAMPINAS, Brazil, 4MEDICAL AUDIT, TNK, CURITIBA PR, Brazil, 5TNK, CURITIBA , PR, Brazil, 6Research Student, TNK, São Paulo, Brazil.
OBJECTIVES: A device for breast disease aims to deliver a safe, effective, non-invasive, easy-to-use technology to support physical breast examination.Update providing an approach to breast healthcare, potentially saving lives . Our aim is to describe the incorporating process for a new device for early detection of breast disease and the consequences for the treatment of breast diseases in Brazil. Since the researchers has given us a chance to contribute to the health care and had a tremendous opportunity to help many women, regardless of their socioeconomic status, with the solution for early breast disease detection , we study this opportunity .
METHODS: RWD & RWE review literature of thermal screening device consisting of two disposable pads with photochromic sensors for Breast ( Celbrea ) .
RESULTS: This approach to breast care allows physicians to evaluate patients’ breast health with a painless procedure and give results and reassurance on the spot. The clinical data showed that is safe, effective, and reliable. Besides, provides a complementary modality to mammography and other established procedures and serves as a valuable additional information in the process of breast disease detection. Women who will benefit the most from this are women with inconclusive imaging results , dense breasts and young women ( less than 40 years ) . 87 % of specificity , 99 % of NPV (negative predictive value) , and 86 % of sensitivity . Given its high NPV, it can support physicians with a more comprehensive clinical decision on next steps. Plus, consistent sensitivity level across tumor size and proven effectiveness across all age groups.
CONCLUSIONS: Our stakeholders perspectives analysis is that who not incorporate this innovation , early , are losing chances of increase sustenability in their health care system by analysis of the waste pharmacoeconomic comparisons tools .
METHODS: RWD & RWE review literature of thermal screening device consisting of two disposable pads with photochromic sensors for Breast ( Celbrea ) .
RESULTS: This approach to breast care allows physicians to evaluate patients’ breast health with a painless procedure and give results and reassurance on the spot. The clinical data showed that is safe, effective, and reliable. Besides, provides a complementary modality to mammography and other established procedures and serves as a valuable additional information in the process of breast disease detection. Women who will benefit the most from this are women with inconclusive imaging results , dense breasts and young women ( less than 40 years ) . 87 % of specificity , 99 % of NPV (negative predictive value) , and 86 % of sensitivity . Given its high NPV, it can support physicians with a more comprehensive clinical decision on next steps. Plus, consistent sensitivity level across tumor size and proven effectiveness across all age groups.
CONCLUSIONS: Our stakeholders perspectives analysis is that who not incorporate this innovation , early , are losing chances of increase sustenability in their health care system by analysis of the waste pharmacoeconomic comparisons tools .
Conference/Value in Health Info
2025-05, ISPOR 2025, Montréal, Quebec, CA
Value in Health, Volume 28, Issue S1
Code
EE27
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis, Thresholds & Opportunity Cost, Trial-Based Economic Evaluation, Value of Information
Disease
SDC: Oncology